Iloprost delivery and efficacy in critically ill patients

K. Harris, G. Smaldone, T. O‘Riordan (Stony Brook, NY, United States Of America)

Source: Annual Congress 2007 - Problems in intensive care medicine
Session: Problems in intensive care medicine
Session type: Thematic Poster Session
Number: 3456
Disease area: Respiratory critical care

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Harris, G. Smaldone, T. O‘Riordan (Stony Brook, NY, United States Of America). Iloprost delivery and efficacy in critically ill patients. Eur Respir J 2007; 30: Suppl. 51, 3456

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The practice of sedation in critically ill patients
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020


Steroid use in elderly critically ill COVID-19 patients
Source: Eur Respir J, 58 (4) 2100979; 10.1183/13993003.00979-2021
Year: 2021



Which tracheostomy in critically ill patients?
Source: Annual Congress 2008 - Tracheostomy in critically ill patients
Year: 2008


Why tracheostomy in critically ill patients?
Source: Annual Congress 2008 - Tracheostomy in critically ill patients
Year: 2008


Efficacy and safety of extended antithrombotic prophylaxis in elderly medically ill patients
Source: Eur Respir J 2017; 49(1): 1601887; DOI: 10.1183/13993003.01887-2016
Year: 2017


Antibiotics in the critically ill and septic patient
Source: Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections
Year: 2013

Impact of pulmonary rehabilitation on sequelae produced in critically ill patients by COVID-19.
Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19
Year: 2021


Morphine use in the treatment of dyspnea in terminally ill patients.
Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Year: 2021


Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia
Source: ERJ Open Res, 7 (1) 00888-2020; 10.1183/23120541.00888-2020
Year: 2021



Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with pulmonary infections
Source: Eur Respir J 2006; 28: Suppl. 50, 275s
Year: 2006

How can I prevent infectious complications in critically ill patients?
Source: Annual Congress 2008 - PG13 - Respiratory failure: skills needed to treat an episode of acute respiratory failure
Year: 2008



Clinically important drug interactions with anti-infective agents in critically ill patients with respiratory disorders
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016

Resistin may predict severity and mortality in critically ill septic patients
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018

Indicators of systemic inflammation in critically ill patients with COVID-19.
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


The effect of pre-hospital anti-platelet therapy in adults with ARDS: A meta-analysis
Source: International Congress 2016 – Sepsis and ARDS: looking forward
Year: 2016



Noninvasive ventilation during the weaning process in chronically critically ill patients
Source: ERJ Open Res, 2 (4) 00061-2016; 10.1183/23120541.00061-2016
Year: 2016



Nutritional status and its impact on the outcome in critically ill COPD patients
Source: Annual Congress 2009 - Intensive care unit management and outcome
Year: 2009


Clinical efficacy of moxifloxacin in severely ill patients with CAP
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009